The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbvie; Amgen; ARIAD; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Lilly/ImClone; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Sanofi; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly/ImClone; MSD Oncology; Pfizer; Roche/Genentech
Updated efficacy and safety data from the global phase III ALEX study of alectinib (ALC) vs crizotinib (CZ) in untreated advanced ALK+ NSCLC.
 
D. Ross Camidge
Honoraria - AstraZeneca; bio-thera; Daiichi Sankyo; G1 therapeutics; Genoptix; Hansoh; Ignyta; Lycera; Mersana; Revolution Medicines; Roche; takeda
Research Funding - Takeda
 
Solange Peters
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen; Merck Serono; MSD; Novartis; Pfizer; Regeneron; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Tony Mok
Employment - The Chinese University of Hong Kong
Leadership - Sanomics Limited
Stock and Other Ownership Interests - Cirina; Sanomics Limited
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - ACEA Biosciences; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Cirina; Clovis Oncology; geneDecode; Ignyta; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Oncogenex; Pfizer; Roche/Genentech; SFJ Pharmaceuticals Group; Vertex
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SFJ Pharmaceuticals Group (Inst); Taiho Pharmaceutical (Inst)
 
Shirish M. Gadgeel
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Pfizer
Speakers' Bureau - AstraZeneca
Research Funding - ACEA Biosciences (Inst); Acerta Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Halozyme (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck; Merck (Inst); Millennium (Inst); Novartis (Inst); OncoMed (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - ARIAD/Takeda; Genentech/Roche
 
Parneet K. Cheema
Honoraria - AstraZeneca; BMS Brazil; Boehringer Ingelheim; Lilly; Merck; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; BMS Brazil; Boehringer Ingelheim; Lilly; Merck; Novartis; Pfizer; Roche; Takeda
Research Funding - Boehringer Ingelheim
 
Nick Pavlakis
Honoraria - Bayer; Boehringer Ingelheim; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; BMS Brazil; Boehringer Ingelheim; Ipsen; Merck KGaA; MSD; Novartis; Pfizer; Roche; Takeda
 
Filippo De Marinis
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Roche
 
Daniil L. Stroyakovskiy
No Relationships to Disclose
 
Byoung Chul Cho
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Roche; Yuhan
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Roche; Yuhan
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis
Research Funding - AstraZeneca; Bayer; Novartis; Novartis
 
Li Zhang
Consulting or Advisory Role - Boehringer Ingelheim; MSD
Research Funding - AstraZeneca; BMS Brazil; Pfizer
 
Denis Moro-Sibilot
No Relationships to Disclose
 
Ali Hassan Zeaiter
Employment - Proacta
Leadership - Proacta
Stock and Other Ownership Interests - Proacta
 
Emmanuel Mitry
Employment - Proacta
Stock and Other Ownership Interests - Proacta
 
Bogdana Balas
Employment - Novartis; Proacta
Stock and Other Ownership Interests - Proacta
 
Barbara Müller
Employment - Proacta
Stock and Other Ownership Interests - Proacta
 
Alice Shaw
Honoraria - Genentech/Roche; Ignyta; Novartis; Pfizer
Consulting or Advisory Role - ARIAD; Blueprint medicines; Genentech/Roche; Ignyta; KSQ Therapeutics; Loxo; Natera; Novartis; Pfizer; Takeda
Research Funding - Genentech/Roche; Novartis; Pfizer